Unknown PHASE4 INTERVENTIONAL 2-arm NCT01117610

A Preemptive Epidural Ropivacaine for Postoperative Pain Relief in Degenerative Lumbar Spine Surgery

A Preemptive Epidural Ropivacaine for Postoperative Pain Relief in Degenerative Lumbar Spine Surgery: A Prospective Randomized Study

Sponsor: Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Conditions Postoperative Pain

Interventions Placebo (one of medication) Ropivacaine (epidural injection)

Updated 5 times since 2017 Last updated: May 4, 2010 Started: May 31, 2010 Primary completion: Apr 30, 2011 Completion: Apr 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01117610, this PHASE4 trial focuses on Postoperative Pain and remains ongoing. Sponsored by Chung-Ang University Hosptial, Chung-Ang University College of Medicine, it has been updated 5 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE4
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2017 — Jan 2021 [monthly]

Unknown Status PHASE4

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chung-Ang University Hosptial, Chung-Ang University College of Medicine

Data source: Chung-Ang University Hosptial, Chung-Ang University College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seoul, South Korea